The first of Trump’s billion-dollar promises to bite the dust

Published 10-MAR-2017 10:31 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

While it was the plunging oil price that mainly drove the Dow lower for most of the trading session there is a larger underlying problem looming as it came to light that the first of President Trump’s major election promises, a US$1 trillion infrastructure spending plan, has no plan.

Not only did Trump not have a plan leading up to the election, but he is now turning to industry to ask the question as to how the program could be funded. Blank faces told the story, as one industry representative reaffirmed that nothing has changed as there is only a limited budget for government funded infrastructure development.

With a seemingly massive black hole in one of Trump’s cornerstone election promises, US investors will soon be questioning whether material tax cuts will occur, and perhaps facing the cold hard facts that the only tangible foundation for the run in equities was a better than expected earnings season, but even this isn’t enough to justify the extent of the post-election rally.

The Dow closed at 20,858 points, a meagre gain of two points, but at one stage was down as much as 78 points.

The NASDAQ trended in similar fashion, falling from the previous day’s close of 5837 points to a low of 5812 points before finishing up one point at 5838 points.

However, much of the focus was on the oversupply of oil which drove a sharp downturn yesterday and underpinned a decline to a low of US$48.59 per barrel, prior to a slight recovery in afternoon trading.

Despite the recovery, a break below US$50 per barrel was seen as extremely negative by technical traders, perhaps signalling the start of a more significant retracement.

European markets were also negatively affected by the slump in the oil price, but positive commentary from European Central Bank President Mario Draghi tended to offset the decline with banks being the major beneficiaries of his insights which suggested deflationary pressures have lessened.

The FTSE 100 finished at 7314 points, a decline of nearly 0.3%, but substantially better than the intraday low of 7264 points.

The DAX was flat, closing at 11,978 points, while the Paris CAC 40 gained 0.4% to finish at 4981 points.

Looking elsewhere on the commodities front, gold has a traditional safe haven investment didn’t benefit from broader market uncertainty as it fell from the previous day’s close of US$1209 per ounce to US$1200 per ounce.

Base metals were mixed, but there were no substantial moves as yesterday sharp decline in the nickel price abated.

The Australian dollar declined slightly and is currently fetching approximately US$0.75.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X